Reentering in Silence: A Thematic Review of Hopes and Post-Release Needs Among Deaf and Hard-of-Hearing Incarcerated People
The Prison Journal · 2026-12 · 106 (6) · 714-729
DOI: 10.1177/00328855261485545 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Prison Journal, online erschienen am 03.09.2026. Verfasst von Dywane Thompson und 1 weiteren Autor:innen. Die Arbeit nennt 19 Literaturangaben.
Abstract (Originalsprache)
As correctional systems shift toward decarceration, reentry risks have become a central policy concern. Yet, the needs of deaf and hard-of-hearing (DHH) individuals remain largely unexplored. This study examines the reentry expectations of 16 incarcerated DHH individuals in the southeastern United States using semi-structured interviews and thematic analysis. Findings reveal a tension between aspirations for employment and family reunification and anticipated vulnerabilities, particularly related to communication barriers, physical safety, and discrimination. Participants highlighted limited access to sign-fluent services and accessible resources. The study underscores the need for communication-accessible, culturally competent reentry planning to reduce isolation and support successful reintegration.
Zitieren
APA
Thompson, D., & Smith, H. P. (2026). Reentering in Silence: A Thematic Review of Hopes and Post-Release Needs Among Deaf and Hard-of-Hearing Incarcerated People. The Prison Journal, 106(6), 714-729. https://doi.org/10.1177/00328855261485545
Vancouver
Thompson D, Smith HP. Reentering in Silence: A Thematic Review of Hopes and Post-Release Needs Among Deaf and Hard-of-Hearing Incarcerated People. The Prison Journal. 2026;106(6):714-729. doi:10.1177/00328855261485545
BibTeX
@article{Thompson2026,
author = {Thompson, Dywane and Smith, Hayden P.},
title = {Reentering in Silence: A Thematic Review of Hopes and Post-Release Needs Among Deaf and Hard-of-Hearing Incarcerated People},
journal = {The Prison Journal},
year = {2026},
volume = {106},
number = {6},
pages = {714--729},
doi = {10.1177/00328855261485545}
}
EUVIMED